Sort by
Refine Your Search
-
George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș | Romania | about 1 month ago
the launch of the recruitment process for the target group within the project “FOCUS: Training and Orientation for UMFST Researchers in Health,” MySMIS code 350717, carried out in partnership with the Târgu
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID
-
Offer Description AS PART OF THE PROJECT “ PNRR” Translational research targeting fibrosis regression, endothelial dysfunction reversal, and hepatocyte regeneration in advanced liver diseases—3RE-VALID